October 14, 2026 Type 1 diabetes briefing: trials, device safety, and research signals
A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.
The short version
The October 14, 2026 feed is strongest in three lanes: device safety, recruiting studies, and recent research records. Type1Cure treats safety and trial records as higher-priority signals because they can affect what a family may need to check, ask, or watch next.
This is not a medical recommendation. It is a source map and plain-English triage layer designed to help families decide what deserves a closer look with their care team.
Signals in the feed
- The Impact of Early Automated Insulin Delivery (AID) Therapy on Diabetes Control and Comorbidities, and Cost-effectiveness of AID Treatment — RECRUITING, NA. Interventions: Omnipod 5, Multiple daily injections of insulin. Locations: Espoo, Finland | Helsinki, Finland. The purpose of this study is to investigate the effect of early initiated automated insulin...Source
- Strategy For Assessing The Risk Of Type 1 Diabetes In Pediatric Celiac Patients — RECRUITING. Locations: Bari, BA, Italy. Celiac disease (CD) and type 1 diabetes mellitus (T1D) are chronic autoimmune disorders that frequently co-occur, largely due to shared genetic susceptibility, particularly HLA-DQ...Source
- Medtronic MiniMed, Inc.: Brand Name: MiniMed Flex Product Name: MiniMed Flex Insulin Pump Model/Catalog Numbers: MMT-8062; MMT-8072 Product Description: The MiniMed Flex pump is an alternate controller en... — Some MiniMed Flex insulin pumps were released with missing (i.e., devices with no result or abort test results are presumed to have failed) or failed verification test results in one or more of 9 functional tests. The u...Source
- Tandem Diabetes Care, Inc.: Brand Name: Tandem t:slim mobile application Product Name: t:slim Mobile Application, iOS Model/Catalog Number: iOS software version 2.13 Software Version: iOS software version 2.... — A beta (early-release) version of the iOS application, version 2.13 (TestFlight) had a software issue preventing successful pairing of the t:slim application with Abbott FreeStyle Libre 3 Plus (FSL3P) continuous glucose...Source
- Effect of Different Carbohydrate Intake Patterns on Glycemic Control in Patients With Type 1 Diabetes — RECRUITING, NA. Interventions: diverse carbohydrate diet, moderate carbohydrate diet. Locations: Nanjing, Jiangsu, China. This multicenter, randomized, controlled, open-label clinical trial aims to evaluate the effects...Source
- Early Detection of Type 1 Diabetes in First Degree Relatives of Type 1 Diabetes Patients (DETECT T1D GULF) — RECRUITING, NA. Interventions: Investigational Procedure. Locations: Kuwait City, Al Asimah / Capital Governorate, Kuwait | Dammam, Eastern Province, Saudi Arabia | Jeddah, Mecca Region, Saudi Arabia. The aim of this re...Source
- Medtronic MiniMed, Inc.: MiniMed 640G Insulin Pump, Model: MMT-1711, MMT-1712; — Loaner insulin pumps may have been cleaned with chemically incompatible products that could damage the pump case or keypad, allow moisture ingress, and result in insulin over- or under-delivery, potentially causing hypo...Source
How to use this briefing
Start with the evidence label. Official registry and regulator records are not the same thing as advice, but they are stronger source material than a repost, rumor, or promotional headline.
For trials, check eligibility, location, burden, intervention, and contact details at the original registry. For device safety, check exact product names, models, lot numbers, software versions, and manufacturer instructions.
This article is an evidence-labeled information brief, not medical advice. Use the linked source records and your care team before making treatment decisions.